Skip Navigation



American Journal of Epidemiology Advance Access published online on August 9, 2007

American Journal of Epidemiology, doi:10.1093/aje/kwm177
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
166/9/1035    most recent
kwm177v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hahn, K. M. E.
Right arrow Articles by Coates, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahn, K. M. E.
Right arrow Articles by Coates, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Published by the Johns Hopkins Bloomberg School of Public Health 2007.

ORIGINAL CONTRIBUTION

Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer

Karin M. E. Hahn1,2, Melissa L. Bondy2, Mano Selvan3, Mary Jo Lund4, Jonathan M. Liff5, Elaine W. Flagg6, Louise A. Brinton7, Peggy Porter8, J. William Eley4 and Ralph J. Coates9

1 Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
2 Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
3 Department of Quality Improvement, The University of Texas M. D. Anderson Cancer Center, Houston, TX
4 Winship Cancer Institute, Emory University, Atlanta, GA
5 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
6 Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
7 Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, MD
8 Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA
9 Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA

Correspondence to Dr. Karin M. E. Hahn, Departments of Breast Medical Oncology and Epidemiology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439 (e-mail: khahn{at}mdanderson.org).

Received for publication January 16, 2007. Accepted for publication May 11, 2007.

Breast cancer is diagnosed at a younger age and a more advanced stage in African-American women than in White women. The authors investigated the effects of several factors, including race, on stage of breast cancer in women aged 20–54 years living in Atlanta, Georgia, and diagnosed between 1990 and 1992. A total of 251 African-American and 580 White women were interviewed and their medical records reviewed. By use of polytomous logistic regression, factors possibly influencing stage and racial differences in stage were studied. In African-American women, the odds of stage III/IV breast cancer at diagnosis were almost four times the odds in White women (odds ratio = 3.79, 95% confidence interval: 2.45, 5.89) and approximately two and one-half times for stage IIA or stage IIB disease (odds ratio = 2.57, 95% confidence interval: 1.66, 3.99; odds ratio = 1.94, 95% confidence interval: 1.31, 2.86, respectively). These racial differences appeared to be largely explained by insurance status, poverty, history of mammography, method of tumor detection, and obesity. Interventions targeting these factors could potentially lower the stage at diagnosis for African-American breast cancer patients and, in doing so, improve their survival and other outcomes.

body mass index; breast neoplasms; demography; ethnic groups; socioeconomic factors

Abbreviations: ER, estrogen receptor; PR, progesterone receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.